ABBOTT INDIA LIMITED vs SUN PHARMACEUTICAL IND L
A side-by-side comparison of ABBOTT INDIA LIMITED (ABBOTINDIA) and SUN PHARMACEUTICAL IND L (SUNPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
ABBOTT INDIA LIMITED and SUN PHARMACEUTICAL IND L are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.
Valuation
How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
How efficiently each company turns capital and sales into profit. Higher is better.
Growth
Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is almost debt free.", "Company has a good return on equity (ROE) track record: 3 Years ROE 35.0%", "Company has been maintaining a healthy dividend payout of 69.6%"]
- − ["Stock is trading at 12.1 times its book value", "The company has delivered a poor sales growth of 9.96% over past five years."]
- + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 34.1%"]
- − ["The company has delivered a poor sales growth of 11.8% over past five years."]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.